Lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Diagnosed as lung cancer through pathological examination and admitted to the hospital for chemotherapy, immunotherapy, or chemotherapy combined with immunotherapy; 2.TNM staging: Stage IIIB or Stage IV; 3.Expected survival time>6 months.
Exclusion criteria
Exclusion criteria: 1.Suffering from mental illness or consciousness disorders; 2.Suffering from serious illnesses in other organs or systems such as the heart, brain, blood vessels, liver and kidney; 3.Suffering from severe visual and auditory impairments; 4.Low compliance or unwillingness to participate in this study. 5.The subject has a history of drug abuse (defined as the use of any prohibited drugs) or alcohol abuse.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical treatment efficacy and adverse reaction characteristics of elderly and young and middle-aged patients;Metabolite levels;Differences in the expression of key genes in the enzymatic process of drug biotransformation; | — |
Countries
China
Contacts
Quzhou People's Hospital